These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 28810280)
1. [Dual Antiplatelet Therapy in the Perioperative Period - To Continue or Discontinue Treatment?]. Koscielny J; von Heymann C; Zeymer U; Cremer J; Spannagl M; Labenz J; Giannitsis E; Goss F Dtsch Med Wochenschr; 2017 Aug; 142(16):1223-1230. PubMed ID: 28810280 [No Abstract] [Full Text] [Related]
2. [Bleeding in patients receiving dual antiplatelet therapy after acute coronary syndrome - significance, prevention and interdisciplinary management]. Zeymer U; Koscielny J; von Heymann C; Spannagl M; Labenz J; Cremer J; Giannitsis E; Darius H; Goss F Dtsch Med Wochenschr; 2016 Jul; 141(15):1107-11. PubMed ID: 27464285 [TBL] [Abstract][Full Text] [Related]
13. Management of acute coronary syndrome in the hospital: a focus on ACCF/AHA guideline updates to oral antiplatelet therapy. Vengoechea F Hosp Pract (1995); 2014 Aug; 42(3):33-47. PubMed ID: 25255405 [TBL] [Abstract][Full Text] [Related]
14. Oral antiplatelet agents for the management of acute coronary syndromes: A review for nurses and allied healthcare professionals. Gesheff T; Barbour C J Am Assoc Nurse Pract; 2017 Feb; 29(2):104-115. PubMed ID: 28139897 [TBL] [Abstract][Full Text] [Related]
15. Clopidogrel, prasugrel, or ticagrelor? a practical guide to use of antiplatelet agents in patients with acute coronary syndromes. Norgard NB; Dinicolantonio JJ Postgrad Med; 2013 Jul; 125(4):91-102. PubMed ID: 23933898 [TBL] [Abstract][Full Text] [Related]
16. Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit? Collet JP; Montalescot G Int J Cardiol; 2009 Mar; 133(1):8-17. PubMed ID: 19187982 [TBL] [Abstract][Full Text] [Related]
17. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor. Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G; Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085 [TBL] [Abstract][Full Text] [Related]
18. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Korte W; Cattaneo M; Chassot PG; Eichinger S; von Heymann C; Hofmann N; Rickli H; Spannagl M; Ziegler B; Verheugt F; Huber K Thromb Haemost; 2011 May; 105(5):743-9. PubMed ID: 21437351 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of universal and platelet reactivity assay-driven antiplatelet therapy in acute coronary syndrome. Coleman CI; Limone BL Am J Cardiol; 2013 Aug; 112(3):355-62. PubMed ID: 23631863 [TBL] [Abstract][Full Text] [Related]
20. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor. Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G; J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]